Treatment of Ampicillin-Susceptible Enterococcus faecium UTI
Ampicillin is the definitive drug of choice for ampicillin-susceptible Enterococcus faecium urinary tract infections. 1, 2
Recommended Treatment Regimen
For Uncomplicated UTI (Oral Therapy)
- Amoxicillin 500 mg orally every 8 hours for 7 days is the preferred first-line oral therapy, achieving clinical cure rates of 88.1% and microbiological eradication rates of 86% 2, 3
- Ampicillin 500 mg orally every 8 hours for 7 days is an equivalent alternative with similar efficacy 2, 3
For Complicated UTI or Hospitalized Patients (IV Therapy)
- High-dose ampicillin 2 g IV every 4-6 hours (18-30 g daily in divided doses) is recommended to achieve sufficient urinary concentrations 2, 4
- The FDA label specifically indicates ampicillin for urinary tract infections caused by susceptible organisms 4
Catheter-Associated UTI Considerations
- Remove the indwelling catheter if clinically feasible, as catheter retention is strongly associated with treatment failure 1
- If catheter removal is not possible, consider antibiotic lock therapy in addition to systemic ampicillin therapy 1
- Treatment duration should be 7-14 days for catheter-associated enterococcal UTI 1
Critical Clinical Decision Points
Confirm True Infection vs. Colonization
- Do not treat asymptomatic bacteriuria, which is extremely common in catheterized patients and treatment fosters antimicrobial resistance 1, 3
- Ensure the patient has symptomatic infection with fever, dysuria, urgency, or systemic signs before initiating therapy 1
Monitor for Complicated Infection
- Evaluate for signs of upper tract involvement including fever, rigors, flank pain, or delirium that would warrant longer therapy 1
- If persistent bacteremia occurs despite appropriate therapy, obtain transesophageal echocardiography to evaluate for endocarditis 1
Alternative Oral Agents (If Ampicillin Cannot Be Used)
- Nitrofurantoin 100 mg orally every 6 hours for 7 days has excellent activity against E. faecium with resistance rates below 6% 2, 3, 5
- Fosfomycin 3 g orally as a single dose is FDA-approved specifically for E. faecalis UTI and provides convenient single-dose therapy for uncomplicated infections 2, 3, 5
Common Pitfalls to Avoid
- Do not use fluoroquinolones despite reported susceptibility, as clinical outcomes are poor and resistance rates are high (46-47% for ciprofloxacin/levofloxacin) 2, 3
- Do not ignore the catheter - failure to address the indwelling catheter significantly increases treatment failure rates 1
- Do not assume resistance based solely on species - E. faecium can be ampicillin-susceptible, particularly clade B and A2 strains, which differ from the typically resistant clade A1 hospital-associated strains 6